Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine (Q51563048)
scientific article published in May 1999
Language:
Current Data About Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
(P31) (Q13442814)
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P304) 805-810
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P407) (Q1860)

(P433) 7
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P478) 13
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P577) Saturday, May 1, 1999
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P1433) (Q4651863)
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P1476) "Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine" (language: en)
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

(P2093) Martínez E
(P1545) 1
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

Conget I
(P1545) 2
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

Lozano L
(P1545) 3
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

Casamitjana R
(P1545) 4
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

Gatell JM
(P1545) 5
(P248)
(P698) 10357379
(P813) Saturday, April 7, 2018
(P854) http://europepmc.org/abstract/MED/10357379

other details
description scientific article published in May 1999

External Links
(P356) 10.1097/00002030-199905070-00009
(P698) 10357379